Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMISA crossover trial of sulthiame and trazodone
ACTRN12625001289404Phase 2Recruiting
- Sponsor
- Monash University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sultiame and trazodone in obstructive sleep apnea hypopnea syndrome (OSAHS) and Insomnia (4 arms), sponsored by Monash University. Primary endpoint: Apnea-hypopnea index (AHI3a). Started Apr 2026; status: recruiting.
02
Drugs
sultiametrazodone
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)Insomnia
Beyond the preview
Go deeper on ACTRN12625001289404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001289404.